Cipla Receives Final Approval for Generic Sustiva® (Efavirenz Tablets 600mg)

“Nicotex Looks Like Regular Chewing Gum; Consumers Tend To Chew It Like That…”

Cipla Opens Up To Crowd Sourcing Innovation

Cipla Receives Final Approval for Generic Isuprel® (Isoproterenol Hydrochloride Injection USP, 0.2mg/mL)

Cipla Limited (“Cipla”), today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single-use sterile Ampoule from the United States Food and Drug Administration (US FDA

    Cipla Receives Final Approval for Generic Isuprel® (Isoproterenol Hydrochloride Injection USP, 0.2mg/mL)

    Cipla partners with Eli Lilly & Company to market diabetes drug BASAGLAR®

    BEST Workers To Get Nicotine Replacement Kits

    Cipla partners with MannKind for exclusive marketing, distribution of Afrezza® - innovative inhaled insulin

    Running The Great Wall Of China To Raise Money For Kidney Disease

    Forbes Emergent 25: Under Samina Vaziralli’s Guidance, Cipla Gets A Shot-In-The-Arm From US Acquisition

    Subscribe to